Development of Low-Molecular-Weight Allosteric Agonist of Thyroid-Stimulating Hormone Receptor with Thyroidogenic Activity

To normalize the thyroid status in hypothyroidism caused by resistance to thyroid-stimulating hormone (TSH), low-molecular-weight allosteric agonists of TSH receptor can be used. A new compound ethyl-2-(4-(4-(5-amino-6-(tert-butylcarbamoyl)-2-(methylthio)thieno[2,3-d]-pyrimidine-4-yl)phenyl)-1H-1,2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhtyukov, A. A., Derkach, K. V., Fokina, E. A., Sorokoumov, V. N., Zakharova, I. O., Bayunova, L. V., Shpakov, A. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2022
Materias:
Biochemistry, Biophysics, and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090882/
https://www.ncbi.nlm.nih.gov/pubmed/35538280
http://dx.doi.org/10.1134/S1607672922020016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090882/
https://www.ncbi.nlm.nih.gov/pubmed/35538280
http://dx.doi.org/10.1134/S1607672922020016

Ejemplares similares